Heparin market

Heparin Market, by Product Type (Unfractionated Heparin (UH), Low Molecular Weight Heparin (LMWH), and Ultra-low Molecular Weight Heparin (ULMW)), by Dosage Form (Injection, and Solutions), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 - 2026

Request Free Sample

May 2019
CMI2602
149 Pages
Excel & Pdf
Pharmaceutical

Summary

Heparin Market – Insights

Heparin is used to prevent or treat certain blood vessel, heart, and lung conditions. It is also used in blood transfusion, blood samplings during prophylaxis treatment, and for treatment of blood clotting disorders Heparin may be used to diagnose and treat a serious blood condition called disseminated intravascular coagulation. Heparin is sometimes used alone or in combination with aspirin to prevent pregnancy loss and other problems.

The global heparin market size was valued at US$ 9.4 billion in 2017 and is expected to witness a CAGR of 5.1% over the forecast period (2018 – 2026).

Global Heparin Market Value (US$ Bn) & Y-o-Y Growth (%)

Source: Coherent Market Insights Analysis (2019)

Increasing incidences of coronary heart disease, pulmonary embolism, and deep vein thrombosis is expected to drive growth of the heparin market

Heparin is widely used clinically for dialysis, deep vein thrombosis (DVT) treatment, and most cardiac surgeries. It is also used to prevent blood clotting during open-heart surgery, kidney dialysis, bypass surgery, and blood transfusions. Kidney dialysis procedure is increasing with rising chronic kidney disease, worldwide. For instance, according to Kidney Care UK 2016 report, about 3 million people in the U.K. are suffering from chronic kidney disease (CKD).

Furthermore, increasing number of surgeries and rising prevalence of diseases such as deep vein thrombosis and coronary heart disease, are fueling demand for heparin, eventually driving growth of the heparin market, during the forecast period. According to the American Heart Association 2018 report, coronary heart disease accounts for 1 in 7 deaths in the U.S., killing over 366,800 people every year. As per the same source, the overall prevalence for myocardial infarction (MI) in the U.S. is about 7.9 million, or 3 percent in U.S. adults.

Heparin Market Restraints

Side effects associated with the use of heparin are the major restraining factors of the market. The main side effect of heparin is bleeding. Heparin can cause spontaneous bleeding from several places in the body including open wounds or surgical sites, intestines and stomach, ovaries and uterus, and mouth and gums. Another serious side effect of heparin is a condition known as heparin-induced thrombocytopenia (HIT) in which heparin induces the body's immune system to develop antibodies against its own platelets, causing risk of bleeding due to reduction in platelets.

Heparin Market - Regional Insights

On the basis of region, the global heparin market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Europe heparin market is expected to generate significant revenue share during the forecast period, owing to growing geriatric population and rising prevalence of long-term survivors of acute myocardial infarction (AMI). Survivors of AMI are at high risk of a recurrent myocardial infarction, as well as other manifestations of cardiovascular disease such as stroke. According to Lancet journal, 2017 report, acute myocardial infarction is the leading cause of hospital admissions and mortality in the UK and across the world.

Asia Pacific heparin market is expected to grow at the highest rate during the forecast period, owing to increasing incidence of myocardial infarction among regional population. According to a study published by National Center for Biotechnology Information (NCBI) in 2015, Asian population is more susceptible to MI than white people. There are 50% higher cases of MI in South Asians than in white people in the UK.

Global Heparin Market Share (%), By Region 2017

Source: Coherent Market Insights Analysis (2019)

Heparin Market - Competitive Landscape

Key players operating in the global heparin market include Anselm Pharmaceuticals, Baxter International Inc., B. Braun Melsungen AG, Bristol-Myers Squibb Co., Dr. Reddy’s Laboratories Ltd., Fresenius SE & Co. KGaA, Leap Labchem Co., LEO Pharma A/S, Pfizer, Inc., Sanofi S.A., Syntex S.A., Teva Pharmaceutical Industries Ltd., and United Biotech (P) Ltd.

Table of Content

Table of Contents

Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

Market Overview

Report Description

Market Definition and Scope

Executive Summary

Market Snippet, By Product Type
Market Snippet, By Dosage Form
Market Snippet, By Region

Coherent Opportunity Map (COM)

Market Dynamics, Regulations, and Trends Analysis

Overview
Market Dynamics

Drivers
Restraints
Market Opportunities

Global Heparin Market, By Product Type, 2016 – 2026, (US$ Million)

Introduction

Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends

Unfractionated Heparin (UH)

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)

Low Molecular Weight Heparin (LMWH)

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)

Ultra-low Molecular Weight Heparin (ULMW)

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)

Global Heparin Market, By Dosage Form, 2016 – 2026, (US$ Million)

Introduction

Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends

Injection

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)

Solution

Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)

Global Heparin Market, By Region, 2016 – 2026, (US$ Million)

Introduction

Market Share Analysis, By Region, 2018 and 2026 (%)
Y-o-Y Growth Analysis, By Region, 2016 – 2026
Regional Trends

North America

Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Dosage Form, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)

U.S.
Canada

Europe

Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Dosage Form, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)

U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe

Asia Pacific

Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Dosage Form, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)

China
Japan
India
ASEAN
Australia
South Korea
Rest of Asia Pacific

Latin America

Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Dosage Form, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)

Brazil
Mexico
Argentina
Rest of Latin America

Africa

Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Dosage Form, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)

Northern Africa
Central Africa
South Africa

Middle East

Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Dosage Form, 2016 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)

GCC Countries
Israel
Rest of Middle East

Competitive Landscape

Heat Map Analysis
Company Profiles

Anselm Pharmaceuticals

Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies

Baxter International Inc.

Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies

B. Braun Melsungen AG

Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies

Bristol-Myers Squibb Co.

Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies

Dr. Reddy’s Laboratories Ltd.

Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies

Fresenius SE & Co. KGaA

Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies

Leap Labchem Co.

Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies

LEO Pharma A/S

Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies

Pfizer, Inc.

Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies

Sanofi S.A.

Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies

Syntex S.A.

Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies

Teva Pharmaceutical Industries Ltd.

Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies

United Biotech (P) Ltd.

Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies

Analyst Views

Section

References
Research Methodology
About Us and Sales Contact

*Browse 33 market data tables and 21 figures on "Heparin Market” - Global forecast to 2026”.

N/A

- Frequently Asked Questions -

What are the growth estimates for heparin market till 2026?

The global heparin market is estimated to surpass US$ 14 Billion by 2026.

Which are the prominent heparin market players across the globe?

Major players operating in the global heparin market include Anselm Pharmaceuticals, Baxter International Inc., B. Braun Melsungen AG, Bristol-Myers Squibb Co., Dr. Reddy’s Laboratories Ltd., Fresenius SE & Co. KGaA, Leap Labchem Co., LEO Pharma A/S, Pfizer, Inc., Sanofi S.A., Syntex S.A., Teva Pharmaceutical Industries Ltd., and United Biotech (P) Ltd.

What are the key factors hampering growth of the heparin market?

Side effects associated with the use of heparin is one of the major factors that is expected to hamper growth of the market over the forecast period.

What are the key factors driving growth of the heparin market?

Increasing incidence of coronary heart disease, pulmonary embolism, and deep vein thrombosis is one of the major factors that is expected to propel growth of the market over the forecast period.

What is the compound annual growth rate (CAGR) of the heparin market for next 8 years?

The global heparin market is estimated to exhibit a CAGR of 5.1% over the forecast period.

Which region is dominating the heparin market growth?

Among regions, Europe is expected to generate significant revenue share during the forecast period, owing to growing geriatric population and rising prevalence of long-term survivors of acute myocardial infarction (AMI).